First Long Island Investors, LLC Vertex Pharmaceuticals Inc Transaction History

First Long Island Investors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$234.96 - $292.55 $3,759 - $4,680	-16 Reduced 1.74%	903 $254,000
Q1 2022 May 09, 2022	SELL	$221.42 - $260.97 $19,484 - $22,965	-88 Reduced 8.74%	919 $240,000
Q4 2021 Feb 04, 2022	BUY	$177.01 - $223.45 $178,249 - $225,014	1,007 New	1,007 $221,000
Q3 2021 Nov 01, 2021	SELL	$181.39 - $202.99 $210,956 - $236,077	-1,163 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $15,107 - $19,818	-67 Reduced 5.45%	1,163 $338,000
Q1 2018 May 04, 2018	BUY	$151.6 - $177.13 $186,468 - $217,869	1,230 New	1,230 $200,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of First Long Island Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on First Long Island Investors, LLC with notifications on news.